| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |